Ardent Health [ARDT] vs Surgery Partners [SGRY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ardent Health Partners Inc. wins in 15 metrics, Surgery Partners Inc. wins in 4 metrics, with 0 ties. Ardent Health Partners Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ardent Health Partners Inc. | Surgery Partners Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.26 | 2,956.00 | Ardent Health Partners Inc. |
| Price-to-Book Ratio | 1.09 | 1.09 | Ardent Health Partners Inc. |
| Debt-to-Equity Ratio | 137.57 | 114.51 | Surgery Partners Inc. |
| PEG Ratio | 8.44 | -34.35 | Ardent Health Partners Inc. |
| EV/EBITDA | 7.09 | 11.42 | Ardent Health Partners Inc. |
| Profit Margin (TTM) | 2.15% | -2.35% | Ardent Health Partners Inc. |
| Operating Margin (TTM) | 6.53% | 15.09% | Surgery Partners Inc. |
| EBITDA Margin (TTM) | 6.53% | 15.09% | Surgery Partners Inc. |
| Return on Equity | 14.35% | 2.76% | Ardent Health Partners Inc. |
| Return on Assets (TTM) | 3.97% | 3.74% | Ardent Health Partners Inc. |
| Free Cash Flow (TTM) | $258.61M | $195.60M | Ardent Health Partners Inc. |
| 1-Year Return | -36.26% | -43.41% | Ardent Health Partners Inc. |
| Price-to-Sales Ratio (TTM) | 0.22 | 0.57 | Ardent Health Partners Inc. |
| Enterprise Value | $3.41B | $7.49B | Surgery Partners Inc. |
| EV/Revenue Ratio | 0.54 | 2.26 | Ardent Health Partners Inc. |
| Gross Profit Margin (TTM) | 42.13% | 23.98% | Ardent Health Partners Inc. |
| Revenue per Share (TTM) | $45 | $26 | Ardent Health Partners Inc. |
| Earnings per Share (Diluted) | $0.96 | $-0.61 | Ardent Health Partners Inc. |
| Beta (Stock Volatility) | N/A | 1.99 | N/A |
| Short % of Float | 8.61% | 22.70% | Ardent Health Partners Inc. |
Ardent Health Partners Inc. vs Surgery Partners Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ardent Health Partners Inc. | -15.53% | -16.70% | -21.54% | -16.79% | -12.32% | -9.38% |
| Surgery Partners Inc. | -1.89% | 0.22% | -4.86% | -2.95% | -20.72% | -11.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ardent Health Partners Inc. | -36.26% | -46.65% | -46.65% | -46.65% | -46.65% | -46.65% |
| Surgery Partners Inc. | -43.41% | -66.42% | -77.94% | -5.72% | -27.51% | -27.51% |
Performance & Financial Health Analysis: Ardent Health Partners Inc. vs Surgery Partners Inc.
| Metric | ARDT | SGRY |
|---|---|---|
| Market Information | ||
| Market Cap | $1.39B | $1.86B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 333,798 | 864,264 |
| 90 Day Avg. Volume | 343,166 | 1,150,188 |
| Last Close | $7.83 | $13.51 |
| 52 Week Range | $7.71 - $15.48 | $11.41 - $24.10 |
| % from 52W High | -49.42% | -43.94% |
| All-Time High | $20.72 (Oct 14, 2024) | $69.58 (Jun 21, 2021) |
| % from All-Time High | -62.21% | -80.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.02% |
| Quarterly Earnings Growth | -0.61% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.02% |
| Operating Margin (TTM) | 0.07% | 0.15% |
| Return on Equity (TTM) | 0.14% | 0.03% |
| Debt to Equity (MRQ) | 137.57 | 114.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.02 | $13.37 |
| Cash per Share (MRQ) | $4.99 | $1.87 |
| Operating Cash Flow (TTM) | $470.51M | $274.30M |
| Levered Free Cash Flow (TTM) | $155.97M | $164.71M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ardent Health Partners Inc. vs Surgery Partners Inc.
| Metric | ARDT (Apr 24, 2026) | SGRY (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.26 | 2,956.00 |
| Forward P/E | 8.44 | 37.68 |
| PEG Ratio | 8.44 | -34.35 |
| Price to Sales (TTM) | 0.22 | 0.57 |
| Price to Book (MRQ) | 1.09 | 1.09 |
| Market Capitalization | ||
| Market Capitalization | $1.39B | $1.86B |
| Enterprise Value | $3.41B | $7.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.54 | 2.26 |
| Enterprise to EBITDA | 7.09 | 11.42 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.99 |
| Book Value per Share (MRQ) | $9.02 | $13.37 |
Financial Statements Comparison: Ardent Health Partners Inc. vs Surgery Partners Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ARDT (2025) | SGRY (2025) |
|---|---|---|
| Revenue/Sales | 6.32B | 3.31B |
| Cost of Goods Sold | 3.74B | 2.54B |
| COGS % of Revenue | 59.1% | 76.9% |
| Gross Profit | 2.58B | 765.00M |
| Gross Margin | 40.9% | 23.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 325.58M | 470.80M |
| Operating Margin | 5.1% | 14.2% |
| EBITDA | 504.61M | 678.40M |
| EBITDA Margin | 8.0% | 20.5% |
| Pre-Tax Income | 286.36M | 116.90M |
| Pre-Tax Income % of Revenue | 4.5% | 3.5% |
| Income Tax | 56.22M | 18.00M |
| Income Tax % of Revenue | 0.9% | 0.5% |
| Net Income (Profit) | 230.14M | 98.90M |
| Profit Margin | 3.6% | 3.0% |
Balance Sheet & Liquidity Metrics
| Metric | ARDT (2025) | SGRY (2025) |
|---|---|---|
| Cash & Equivalents | 709.60M | 239.90M |
| Total Current Assets | 2.06B | 1.15B |
| Total Current Assets % of Revenue | 32.6% | 34.8% |
| Total Current Liabilities | 1.05B | 615.50M |
| Total Current Liabilities % of Revenue | 16.5% | 18.6% |
| Long-Term Debt | 2.24B | 3.88B |
| Long-Term Debt % of Revenue | 35.4% | 117.4% |
| Total Shareholders Equity | 1.68B | 3.53B |
| Retained Earnings | 501.61M | -815.20M |
| Retained Earnings % of Revenue | 7.9% | -24.6% |
| Property, Plant & Equipment | 2.51B | 1.60B |
Cash Flow Statement Comparison
| Metric | ARDT (2025) | SGRY (2025) |
|---|---|---|
| Operating Cash Flow | 592.45M | 243.40M |
| Operating Cash Flow % of Revenue | 9.4% | 7.4% |
| Capital Expenditures | -211.90M | -32.20M |
| Free Cash Flow | 258.61M | 195.60M |
| FCF Margin | 4.1% | 5.9% |
| Debt Repayment | -7.99M | -1.04B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ARDT | SGRY |
|---|---|---|
| Shares Short | 2.84M | 14.00M |
| Short Ratio | 7.12 | 7.57 |
| Short % of Float | 8.61% | 22.70% |
| Shares Outstanding | 142.86M | 129.32M |
| Float Shares | 23.89M | 55.54M |
| % Held by Insiders | 23.42% | 1.53% |
| % Held by Institutions | 74.79% | 122.23% |
| % Held by Public | 1.79% | -23.76% |
Dividend Analysis & Yield Comparison: Ardent Health Partners Inc. vs Surgery Partners Inc.
| Metric | ARDT | SGRY |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |